Structure and function of the human MHC class Ib molecules HLA-E, HLA-F and HLA-G
- PMID: 9700506
- DOI: 10.1111/j.1600-065x.1998.tb01192.x
Structure and function of the human MHC class Ib molecules HLA-E, HLA-F and HLA-G
Abstract
The major histocompatibility (MHC) class Ib molecules HLA-E, HLA-F and HLA-G are relatively non-polymorphic compared to class Ia molecules. Both HLA-E and HLA-G bind peptides and are involved in natural killer (NK)-cell recognition, but the role of HLA-F is unclear. HLA-E binds specifically to the conserved leader sequence peptides from the class Ia MHC molecules and interacts on the cell surface with the CD94/NKG2 class of NK-cell receptors. The framework structure of HLA-E is similar to that of the MHC class Ia molecules, but the peptide-binding groove is highly adapted for the specific binding of the leader sequence peptides. This is different from class Ia molecules, which have highly promiscuous peptide-binding grooves. The HLA-E groove makes full use of all the available pockets and imposes specificity along the entire length of the peptide. HLA-G binds nonamer peptides with leucine or isoleucine at position 2, proline at position 3 and leucine at position 9. Expression of HLA-G inhibits NK cells expressing the CD94/NKG2 class of receptors, though an interaction with these receptors has not been directly demonstrated.
Similar articles
-
Subtle changes in peptide conformation profoundly affect recognition of the non-classical MHC class I molecule HLA-E by the CD94-NKG2 natural killer cell receptors.J Mol Biol. 2008 Apr 11;377(5):1297-303. doi: 10.1016/j.jmb.2008.01.098. Epub 2008 Feb 12. J Mol Biol. 2008. PMID: 18339401 Review.
-
HLA-E and HLA-E-bound peptides: recognition by subsets of NK and T cells.Curr Pharm Des. 2009;15(28):3336-44. doi: 10.2174/138161209789105207. Curr Pharm Des. 2009. PMID: 19860683 Review.
-
HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer.Eur J Immunol. 1998 Sep;28(9):2854-63. doi: 10.1002/(SICI)1521-4141(199809)28:09<2854::AID-IMMU2854>3.0.CO;2-W. Eur J Immunol. 1998. PMID: 9754572
-
Natural killer cell recognition of HLA class I molecules.Rev Immunogenet. 2000;2(3):433-48. Rev Immunogenet. 2000. PMID: 11256749 Review.
-
Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis.J Exp Med. 1998 Mar 2;187(5):813-8. doi: 10.1084/jem.187.5.813. J Exp Med. 1998. PMID: 9480992 Free PMC article.
Cited by
-
Single-cell RNA-seq variant analysis for exploration of genetic heterogeneity in cancer.Sci Rep. 2019 Jul 2;9(1):9524. doi: 10.1038/s41598-019-45934-1. Sci Rep. 2019. PMID: 31267007 Free PMC article.
-
HLA-G expression in gastric carcinoma: clinicopathological correlations and prognostic impact.Virchows Arch. 2018 Oct;473(4):425-433. doi: 10.1007/s00428-018-2379-0. Epub 2018 May 29. Virchows Arch. 2018. PMID: 29845360
-
Tumor escape mechanisms: potential role of soluble HLA antigens and NK cells activating ligands.Tissue Antigens. 2008 Oct;72(4):321-34. doi: 10.1111/j.1399-0039.2008.01106.x. Epub 2008 Aug 12. Tissue Antigens. 2008. PMID: 18700879 Free PMC article. Review.
-
IL-27 driven upregulation of surface HLA-E expression on monocytes inhibits IFN-γ release by autologous NK cells.J Immunol Res. 2014;2014:938561. doi: 10.1155/2014/938561. Epub 2014 Mar 10. J Immunol Res. 2014. PMID: 24741633 Free PMC article.
-
Increased HLA-E expression in white matter lesions in multiple sclerosis.Immunology. 2012 Dec;137(4):317-25. doi: 10.1111/imm.12012. Immunology. 2012. PMID: 23039207 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials